Tag: Cancer: Lymphoma
Recommendations Issued for R/R Pediatric Hodgkin Lymphoma
Recommendations developed for salvage therapy for pediatric patients with first relapse/refractory cHL
Thoracic Radiation May Increase Fatigue, Dyspnea in Short Term
In patients with lung cancer or lymphoma, increase in heart dose tied to decrease in physical activity
Nitrite Consumption May Up Risk for Non-Hodgkin Lymphoma
Nitrite intake linked to carcinogenicity leading to NHL, development of diffuse large B cell lymphoma
Survival Worse for Nonwhite Children With Hodgkin Lymphoma
Risk for postrelapse mortality 2.7-, 3.5-fold higher for Hispanics, non-Hispanic blacks versus whites
ASH: AlloHSCT Feasible After PD-1, PD-L1 mAb in Hodgkin Lymphoma
Outcomes good for those treated with a PD-1 or PD-L1 inhibitor before undergoing allogeneic HSCT
ASH: PET Helps Tailor Therapy in Limited-Stage DLBCL
Most patients had negative PET scan and completed one additional R-CHOP cycle without radiation
Risk for Hodgkin Lymphoma Increased With Allergic Disease, Eczema
Associations attenuated but remained significant after adjustment for steroid use
Testosterone Replacement May Benefit Younger Male Cancer Survivors
Benefits include significant improvement in body composition measurements over six months
Predictors of Immune Response to Hep B Shot ID’d in Lymphoma
Dose and frequency of vaccination, sex, Ann Arbor stage, ibrutinib impact immunity effects of vaccine
Risk for Secondary Primary Cancer Varies With Lymphoma Stage
Risk for SPMs differs over time for survivors of diffuse large B-cell lymphoma according to stage at diagnosis
